🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

7,888 results for “1” Clear

  1. Conoxia® Vloeibaar, 100% v/v, medicinaal gas, cryogeen

    Disc Medicine

    Pulmonary Hypertension, Coronary Microvascular Dysfunction, Hypoxia, Heart Failure

    approved small molecule active

    1 trial

  2. Cormeto 250 mg capsule molli

    Istituto Gentili S.r.l.

    patients with adrenal incidentalomas and subclinical/mild Cushing’s syndrome

    approved small molecule active

    1 trial

  3. Covid-19 vaccine (0-1-4 schedule)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19 Pneumonia

    approved mab active

    2 trials

  4. Cymbalta 30 mg hard gastro-resistant capsules, Vimpat 50 mg film-coated tablets

    Disc Medicine

    chemotherapy-induced neuropathic pain

    approved small molecule active

    1 trial

  5. D-CURE 25000 UI gélules., Placebo of vitamin D

    Laboratoire HRA Pharma

    Periodontitis

    approved small molecule active

    1 trial

  6. DONEPEZIL, DONEPEZIL

    Pari Pharma GmbH

    Interest of adding donepezil to the non-medicinal care pathway recommended in France for Alzheimer's disease

    approved small molecule active

    1 trial

  7. DOTAREM 0,5 mmol/ml oplossing voor injectie in injectieflacons.

    Disc Medicine

    Breast Cancer

    approved small molecule active

    1 trial

  8. DS-8201a

    AstraZeneca AB

    Treatment of patients with HER2-positive breast cancer with or without brain metastasis

    approved small molecule active

    1 trial

  9. DUPILUMAB, Upadacitinib, Upadacitinib

    AbbVie Deutschland GmbH & Co. KG

    Atopic Dermatitis

    approved small molecule active

    1 trial

  10. Dapagliflozin (5-10 mg daily) - SGLT2 Inhibitor Therapy

    The University of Hong Kong

    Fontan

    approved small molecule active

    1 trial

  11. Dapagliflozin 10 MG

    The First People's Hospital of Lianyungang

    Type 2 Diabetes Mellitus

    approved small molecule active

    1 trial

  12. Deltius 50.000 UI cápsulas duras. Colecalciferol (Vitamina D3), CALCIFEDIOL

    Lacuna Pharma Pty Ltd

    Severe vitamin D deficiency

    approved small molecule active

    1 trial

  13. Denominación Común Internacional (DCI): placebo (Suero fisiológico) Denominación Química: Cloruro Sódico 0.9% Forma molecular: NaCl Composición cuali y cuantitativa: 9mg/ml Forma farmacéutica: solución para pulverización nasal Dosis y vía de administración: 0.6ml/ día (6 pulverizaciones ) vía intranasa, Syntocinon 40 U.I./ml Solução para pulverização nasal

    The George Institute

    Borderline Personality Disorder.

    approved small molecule active

    1 trial

  14. Dexamethasone 4 mg tablets, Dexamethasone Phosphate 4 mg/ml Solution for Injection

    Disc Medicine

    Solid tumors

    approved small molecule active

    1 trial

  15. Doxorubicin Accord 2 mg/ml koncentrat till infusionsvätska, lösning, Paclitaxel Accord 6 mg/ml koncentrat till infusionsvätska, lösning, Docetaxel Ebewe 10 mg/ml koncentrat till infusionsvätska, lösning, Epirubicin Accord 2 mg/ml injektions-/infusionsvätska, lösning, Sendoxan pulver till injektionsvätska, lösning

    The George Institute

    Breast cancer female NOS

    approved small molecule active

    1 trial

  16. Dupilumab SAR231893

    Regeneron UK Limited

    Atopic Dermatitis

    approved small molecule completed

    1 trial

  17. Dupilumab SAR231893

    Regeneron UK Limited

    Dermatitis Atopic

    approved small molecule completed

    2 trials

  18. Dupilumab SAR231893

    Regeneron UK Limited

    Chronic Rhinosinusitis With Nasal Polyps

    approved small molecule completed

    1 trial

  19. Dupilumab, dupilumab placebo, solution for injection in pre-filled syringe

    Sanofi-aventis Healthcare Pty Ltd

    Asthma

    approved small molecule active

    1 trial

  20. Dupilumab, matched placebo for test product, Ventolin Evohaler 100 micrograms

    Sanofi-aventis Healthcare Pty Ltd

    Respiratory tract diseases

    approved small molecule active

    1 trial

  21. Dysport 300 E, poeder voor oplossing voor injectie

    Disc Medicine

    Dystonic tremor syndrome

    approved small molecule active

    1 trial

  22. EFFIMIA 0,250 mg/0,035mg, Compresse

    Italfarmaco S.p.A.

    Female contraception.

    approved small molecule active

    1 trial

  23. ENDORET-PRGF

    The George Institute

    pterygium

    approved small molecule active

    1 trial

  24. ENZALUTAMIDE, DOCETAXEL, ABIRATERONE

    Fondazione Telethon ETS

    metastatic castration resistant prostate cancer without mutations of BRCA1/2 genes or unknown

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources